Abstract
Standard therapy for years was on-demand therapy. Readers will learn of results of clinical experience in many different countries with a prophylactic approach to therapy as well as ongoing experimental designs to define optimal therapy. The costs of current prophylaxis regimens will be discussed.
| Original language | English |
|---|---|
| Pages (from-to) | 55-60 |
| Number of pages | 6 |
| Journal | Seminars in Thrombosis and Hemostasis |
| Volume | 29 |
| Issue number | 1 |
| DOIs | |
| State | Published - Feb 2003 |
Keywords
- Cost
- Factor concentrates
- Hemophilia
- Orthopedic outcomes
- Prophylaxis